Results 191 to 200 of about 39,319 (333)
Kinetics of CLL cells in tissues and blood during therapy with the BTK inhibitor ibrutinib
Dominik Wodarz+9 more
openalex +1 more source
Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103 [PDF]
Chaitra S. Ujjani+14 more
openalex +1 more source
Ibrutinib is an effective treatment for B‐cell prolymphocytic leukaemia [PDF]
Max J. Gordon+4 more
openalex +1 more source
Simulation Model of Ibrutinib for Chronic Lymphocytic Leukemia (CLL) With Prior Treatment
Feng Pan+6 more
openalex +1 more source
Effects of ibrutinib treatment on murine platelet function during inflammation and in primary hemostasis [PDF]
Robert H. Lee+3 more
openalex +1 more source
Progressive multi‐focal leucoencephalopathy among ibrutinib‐treated persons with chronic lymphocytic leukaemia [PDF]
Charles L. Bennett+8 more
openalex +1 more source